News 2022-04-15T16:50:08+00:00

In The News

The Change Maker Series – Vicki Vakiener

Meet Vicki Vakiener - Commercial Business Consultant, Chimerix - Member Board of Directors, and serious bargain hunter. Vicki Vakiener, a leader in marketing and commercial operations speaks to us about her career journey, her optimism about healthcare, and the one piece of advice she would share on navigating your career. [...]

By | March 31st, 2022|News|

The Change Maker Series – Deanna Darlington

Meet Deanna Darlington - Principal at Innopiphany, avid traveler, and foodie. Deanna Darlington, a leader in patient engagement and health equity speaks to us about her career journey, her passion for change, and what makes her tick. https://innopiphany.com/the-change-maker-series-deanna-darlington/five-questions/      

By | March 29th, 2022|News|

Digital DNA Enables the Real-World Evidence Ecosystem to Improve Patient Outcomes

Cultivating Digital DNA (Data, Networks, and Applications) Enables a Thriving Real-World Evidence Ecosystem to Improve Patient Outcomes An evolution of medical diagnostics, treatments, and services relies upon a multitude of trusted vendors collectively developing “Digital DNA” — scaled medical datasets, diverse provider networks, and cutting-edge software applications. by Allison Robbins, [...]

By | October 25th, 2021|Publications|

Radar On – December 2018: HHS Proposal Could Reduce Costs but May Harm Patient Care

Radar On – December 2018: HHS Proposal Could Reduce Costs but May Harm Patient Care "If the proposed changes to the protected classes are implemented, “the effect on patients and prescribers will be greater delay, less choice or options and more administrative/time costs to secure the treatments that are best [...]

By | January 2nd, 2019|News|

Radar On – October 2018: HHS Wants to See WACs in TV Ads

Radar On – October 2018: HHS Wants to See WACs in TV Ads “Transparency in the prices of health care services is always a good thing — but finding the prices of drugs is generally easier for patients to find than other health care services that they get. More importantly, [...]

By | January 2nd, 2019|News|

Radar On – September 2018: CVS Will Exclude Certain Drugs Based on ICER Analyses of QALY

Radar On – September 2018: CVS Will Exclude Certain Drugs Based on ICER Analyses of QALY “The question is how this will affect innovative drugs where there are fewer alternatives for patients. Any decision to use this approach needs to also be carefully evaluated in the context of how it [...]

By | January 2nd, 2019|News|